The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for Aucatzyl (obecaktagene autoleucel), its ...
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...
It said the FDA’s approval of Aucatzyl was based on data from the ‘FELIX ... Around 8,400 new cases of ALL are diagnosed ...
TipRanks on MSN11h
Syncona’s Autolus Gains FDA Approval for Leukemia TherapySyncona Shs GBP (GB:SYNC) has released an update. Syncona’s portfolio company, Autolus Therapeutics, has received FDA approval for AUCATZYL®, a ...
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Diltiazem Hydrochloride ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
The US Food and Drug Administration (FDA) sometimes allows cancer drugs with accelerated approvals to remain on the market ...
The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.
The FDA is expected to decide on treatments for familial chylomicronemia syndrome, type 1 diabetes, short bowel syndrome, and Prader-Willi syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback